You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博瑞醫藥(688166.SH):與華潤三九簽署合作研發協議
格隆匯 08-01 15:37

格隆匯8月1日丨博瑞醫藥(688166.SH)公佈,公司及全資子公司博瑞製藥(蘇州)有限公司(以下簡稱“博瑞製藥”)、博瑞新創生物醫藥科技(無錫)有限公司(該三家許可方統稱為“博瑞醫藥及關聯公司”)與華潤三九醫藥股份有限公司(以下簡稱“華潤三九”)簽署了《合作研發協議》,就BGM0504注射液在中國大陸地區(不包含香港、澳門及台灣地區)的研發、註冊、生產及商業化達成合作,博瑞醫藥及關聯公司授予華潤三九一項僅與博瑞醫藥及關聯公司合作的可分許可的排他性合作開發實施許可及一項可分許可的獨佔性商業化實施許可。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account